Abiopharma

🔍 McBee Brannin (Executive)

Company: CoreWeave, Inc. (CRWV)

Report Date: 2026-03-30

Detailed Transactions and Holdings:

• Acquired 16,665 shares of Class A Common Stock (Direct)
  Date: 2026-03-30 | Code: C | equity_swap_involved: 0 | shares_owned_after: 16,665.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 5,524 shares of Class A Common Stock at $67.6696 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,141.00 | transaction_form_type: 4 | Footnotes: F3, F4, F2
• Sold 3,500 shares of Class A Common Stock at $68.766 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,641.00 | transaction_form_type: 4 | Footnotes: F3, F5, F2
• Sold 3,941 shares of Class A Common Stock at $69.6672 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,700.00 | transaction_form_type: 4 | Footnotes: F3, F6, F2
• Sold 2,075 shares of Class A Common Stock at $70.5604 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,625.00 | transaction_form_type: 4 | Footnotes: F3, F7, F2
• Sold 800 shares of Class A Common Stock at $71.6647 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 825.00 | transaction_form_type: 4 | Footnotes: F3, F8, F2
• Sold 375 shares of Class A Common Stock at $72.672 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 450.00 | transaction_form_type: 4 | Footnotes: F3, F9, F2
• Sold 325 shares of Class A Common Stock at $74.3454 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 125.00 | transaction_form_type: 4 | Footnotes: F3, F10, F2
• Sold 125 shares of Class A Common Stock at $75.19 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F11, F2
• Acquired 6,250 shares of Class A Common Stock (Direct)
  Date: 2026-03-30 | Code: C | equity_swap_involved: 0 | shares_owned_after: 6,250.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 2,072 shares of Class A Common Stock at $67.6694 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,178.00 | transaction_form_type: 4 | Footnotes: F3, F4, F12
• Sold 1,313 shares of Class A Common Stock at $68.7659 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,865.00 | transaction_form_type: 4 | Footnotes: F3, F5, F12
• Sold 1,478 shares of Class A Common Stock at $69.6673 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,387.00 | transaction_form_type: 4 | Footnotes: F3, F6, F12
• Sold 778 shares of Class A Common Stock at $70.5606 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 609.00 | transaction_form_type: 4 | Footnotes: F3, F7, F12
• Sold 300 shares of Class A Common Stock at $71.6644 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 309.00 | transaction_form_type: 4 | Footnotes: F3, F8, F12
• Sold 141 shares of Class A Common Stock at $72.673 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 168.00 | transaction_form_type: 4 | Footnotes: F3, F9, F12
• Sold 121 shares of Class A Common Stock at $74.3468 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 47.00 | transaction_form_type: 4 | Footnotes: F3, F10, F12
• Sold 47 shares of Class A Common Stock at $75.186 per share (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F11, F12
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-30 | Code: H | nature_of_ownership: Canis Major SM Trust | shares_owned_after: 54,000.00 | Footnotes: F13
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-30 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 1,800.00 | Footnotes: F14
• Sold 16,665 shares of Class B Common Stock (Derivative)
  Date: 2026-03-30 | Code: C | equity_swap_involved: 0 | shares_owned_after: 4,017,237.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2
• Sold 6,250 shares of Class B Common Stock (Derivative)
  Date: 2026-03-30 | Code: C | equity_swap_involved: 0 | shares_owned_after: 598,705.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F12
• Holds 324,000 shares of Class B Common Stock (Derivative)
  Date: 2026-03-30 | Code: H | shares_owned_after: 324,000.00 | Footnotes: F1, F1, F1, F15
• Holds 108,600 shares of Class B Common Stock (Derivative)
  Date: 2026-03-30 | Code: H | shares_owned_after: 108,600.00 | Footnotes: F1, F1, F1, F16
• Holds 1,582,773 shares of Class B Common Stock (Derivative)
  Date: 2026-03-30 | Code: H | shares_owned_after: 1,582,773.00 | Footnotes: F1, F1, F1, F2
• Holds 122,000 shares of Class B Common Stock (Derivative)
  Date: 2026-03-30 | Code: H | shares_owned_after: 122,000.00 | Footnotes: F1, F1, F1, F17
• Holds 263,795 shares of Class B Common Stock (Derivative)
  Date: 2026-03-30 | Code: H | shares_owned_after: 263,795.00 | Footnotes: F1, F1, F1, F12

Footnotes:

• F1: Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
• F2: The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary.
• F3: The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2025.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.19 to $68.18, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.19 to $69.18, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.19 to $70.17, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.19 to $71.18, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.27 to $72.15, inclusive.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.31 to $73.14, inclusive.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.93 to $74.55, inclusive.
• F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.05 to $75.35, inclusive.
• F12: The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee.
• F13: The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.
• F14: The reported securities are directly held of record by the reporting person's child.
• F15: The reported securities are directly held by the Canis Major 2024 Irrevocable Trust LLC of which the reporting person serves as manager.
• F16: The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.
• F17: The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.
• REMARKS: This Form 4 is Part 2 of 2 for this reporting person. Transactions by the reporting person are continued on this Part 2.